Welcome!
B. Braun Medical SAS (B Braun)
Results
Trendlines to report a loss for 1HFY2022 with US$7.9 mil portfolio company write-off
Trendlines is expected to report its results on Aug 10.
July 27, 2022
Trendlines reveals MVP Stimatix valued at US$43 mil
SINGAPORE (Apr 9): The Trendlines Group has revealed that colostomy-device company Stimatix GI is its “Most Valuable Portfolio" company.
April 09, 2018